Myriad Genetics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Myriad Genetics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11% to $753,200,000. Profit margin reached -35%. Total operating expenses were $774,400,000.

Profit Margin

Myriad Genetics, Inc. (LSE:0K3W.L): Profit margin
2015 723.1M 80.2M 11.09%
2016 753.8M 125.3M 16.62%
2018 772.6M 131M 16.96%
2019 851.1M 4.6M 0.54%
2020 557M -223.7M -40.16%
2021 690.6M -27.2M -3.94%
2022 678.4M -112M -16.51%
2023 753.2M -263.3M -34.96%

0K3W.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2018 2017 2015 2014
Revenue
Revenue
753.2M678.4M690.6M557M851.1M772.6M753.8M723.1M
Cost of revenue
236.2M202M197.6M178.2M201M177.2M157.3M147.4M
Gross profit
517M476.4M493M378.8M650.1M595.4M596.5M575.7M
Operating exp.
Research and development
88.7M85.4M81.9M80.9M85.9M70.8M70.6M75.5M
Selling and marketing
00000000
Total operating expenses
774.4M600.1M681.7M653.3M641.4M537.9M429.7M441.5M
Operating income
-257.4M-123.7M-48.7M-194.8M7.6M118.7M166.8M134.2M
Other income (expenses), net
-4.8M-16.9M-8.4M-88.9M100K60.8M1.2M300K
Income before tax
-262.2M-140.6M-57.1M-283.7M7.7M116.9M168.9M134.9M
Income tax expense
1.1M-28.6M-29.9M59.9M-4.4M-13.9M43.6M54.7M
Net income
-263.3M-112M-27.2M-223.7M4.6M131M125.3M80.2M
Earnings per share
Basic EPS
-3.18-1.39-0.35-2.990.061.891.791.12
Diluted EPS
-3.18-1.39-0.35-2.990.061.821.711.08
Data sourceData sourceData sourceData sourceData sourceData sourceData source